{"id":"W4379802158","doi":"10.1136/annrheumdis-2023-eular.1264","title":"AB1097 MALIGNANCIES WITH LONG-TERM USE OF IXEKIZUMAB IN ADULTS WITH PSORIASIS, PSORIATIC ARTHRITIS, OR AXIAL SPONDYLOARTHRITIS: A POST-HOC ANALYSIS OF DATA FROM 25 RANDOMIZED CLINICAL TRIALS","year":2023,"lang":"en","type":"article","venue":"","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Memorial University of Newfoundland","funders":"Janssen Research and Development; Castle Biosciences; Incyte; UCB Pharma; Regeneron Pharmaceuticals; LEO Pharma; Forté Foundation; Gilead Sciences; GlaxoSmithKline; Amgen; Helsinn Therapeutics; Meiji Seika Pharma; Pfizer; Celgene; Ortho Dermatologics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ixekizumab; Psoriatic arthritis; Psoriasis; Post-hoc analysis; Clinical trial; Dermatology; Arthritis; Axial spondyloarthritis; Physical therapy; Internal medicine; Secukinumab; Sacroiliitis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0203845,0.001332512,0.003847525,0.001165313,0.0002605121,0.001920522,0.0007275701,0.0008873246,0.002724577],"category_scores_gemma":[0.01614028,0.0005676443,0.01897248,0.001854133,0.0005523755,0.001119777,0.0009624165,0.00136461,0.0002004056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000802652,"about_ca_system_score_gemma":0.001346849,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001387887,"about_ca_topic_score_gemma":0.002713861,"domain_scores_codex":[0.9793754,0.01428877,0.002500876,0.001950033,0.001171056,0.000713889],"domain_scores_gemma":[0.9816287,0.01160855,0.004417337,0.001197559,0.0006215682,0.0005262505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.2692029,0.0005588904,0.08495824,0.008438184,0.6089467,0.0002084663,0.0001221382,0.001934704,0.002081811,0.0001354767,0.001321298,0.02209118],"study_design_scores_gemma":[0.1052656,0.03508735,0.2369179,0.001275972,0.6074798,0.0004401443,0.000258536,0.003827713,0.002418918,0.0004240056,0.006492944,0.0001110402],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9085657,0.07759363,0.002734335,0.000506648,0.000347049,0.002177164,0.006176814,0.0001117859,0.001786855],"genre_scores_gemma":[0.9902707,0.004588766,0.001444614,0.000325807,0.0001510198,0.0009130128,0.001786623,0.00002820928,0.0004912563],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0203845,"threshold_uncertainty_score":0.1078048,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1447343361349628,"score_gpt":0.4129401954264452,"score_spread":0.2682058592914824,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}